Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
06/1997
06/11/1997EP0394409B1 Macrophage-derived inflammatory mediator (mip-2)
06/11/1997CN1151760A Serum paraoxonase
06/11/1997CN1151759A Antibodies which bind to insect jut proteins and their use
06/10/1997US5637686 Tata-binding protein associated factor, nucleic acids
06/10/1997US5637677 Biologically active compounds and methods of constructing and using the same
06/10/1997US5637569 Ganglioside analogs
06/10/1997US5637493 Carcinoma associated antigen (SK1) monoclonal antibodies against SK1, methods of producing these antibodies and use therefor
06/10/1997US5637487 Genetic engineered polypeptide; used for immunization of chickens against coccidiosis
06/10/1997US5637481 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
06/10/1997US5637470 Screening array using cells expressing recombinant α and β subunits of the mammalian large-conductance (maxi-K) potassium channel
06/10/1997US5637455 HIV-2 virus variants
06/10/1997US5637300 Contraceptive vaccine comprising a glycosylated 55 kD zona pellucida protein immunogen and method of use of the same in contraception
06/05/1997WO1997020078A1 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
06/05/1997WO1997020063A1 THEREAPEUTIC APPLICATIONS FOR THE ANTI-T-BAM (CD40-L) MONOCLONAL ANTIBODY 5c8
06/05/1997WO1997020054A1 Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them
06/05/1997WO1997020048A2 Modified sfv molecules which mediate adhesion between cells and uses thereof
06/05/1997WO1997020041A1 Method for solubilizing proteins in organic solvents
06/05/1997WO1997019957A1 High efficiency tissue specific compound delivery system using streptavidin-protein a fusion protein
06/05/1997WO1997019952A1 The ob receptor and methods of diagnosing and treating weight
06/05/1997WO1997019950A1 Topiramate immunoassay, as well as analogs and antibodies
06/05/1997WO1997012036A3 Bone stimulating factor
06/05/1997CA2238569A1 The ob receptor and methods of diagnosing and treating weight
06/05/1997CA2238568A1 Method for solubilizing proteins in organic solvents
06/04/1997EP0776972A1 GENE CODING FOR IgG-Fc-BINDING PROTEIN
06/04/1997EP0776906A2 Sm-D peptide antigens and their use especially in the diagnosis of systemic lupus erythromatodes
06/04/1997EP0776370A1 Human erythropoietin receptor fragment and antibodies thereto
06/04/1997EP0776366A1 Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2
06/04/1997EP0776365A2 Retinoblastoma protein-interacting zinc finger proteins
06/04/1997EP0776364A1 Glutamate receptor
06/04/1997EP0776338A1 Immunoconjugates comprising tyrosine kinase inhibitors
06/04/1997EP0776337A1 Growth differentiation factor-11
06/04/1997EP0776336A1 Vitronectin binding protein
06/04/1997EP0776217A1 A method of treating a patient with a biologically active compound
06/04/1997EP0776209A1 Polynucleic acids and proteins from a porcine reproductive and respiratory syndrome virus and uses thereof
06/04/1997EP0680607A4 Assay method to rule out rupture of membranes in women at risk for imminent delivery.
06/04/1997EP0544861A4 Immunoassay for non-a non-b hepatitis
06/04/1997EP0411018B1 Detection, quantitation and classification of ras proteins in body fluids and tissues
06/04/1997CN1151184A Human Monoclonal antibodies specific to cell cycle independent glioma surface antigen
06/04/1997CN1151183A RPS 2 gene and uses thereof
06/04/1997CN1151167A Isolated MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof
06/04/1997CN1151120A Method and compositions useful for inhibition of angiogenesis
06/03/1997US5635617 Methods and compositions comprising the agfA gene for detection of Salmonella
06/03/1997US5635603 Antibody fragment covalently bound to diagnostic or therapeutic principle through carbohydrate moiety
06/03/1997US5635602 Design and synthesis of bispecific DNA-antibody conjugates
06/03/1997US5635601 Beta-8 integrin subunit antibodies
06/03/1997US5635600 Bifunctional and heteroantibodies specific for the high affinity Fc receptor for immunoglobulin G on human mononuclear phagocytes
06/03/1997US5635599 Circularly permuted il4, il2, granulocyte macrophage colony stimulating factor or granulocyte colony stimulating factor fused to a cytotoxin, i.e., pseudomonas exotoxin, diphtheria toxin without the native receptor-binding domain; cancer
06/03/1997US5635388 Monoclonal antibody produced by a hybridoma cell binds to the extracellular domain of flk2/flk3 and activates the intracellular tyrosine kinase domain enhancing repopulation of myeloid and lymphoid blood cell lineages with cytokines
06/03/1997US5635374 Bone calcification factor and recombinant production of the factor nucleic acid encoding
06/03/1997US5635372 BMP-15 compositions
06/03/1997US5635359 Method for measuring the activity of angiotensin converting enzyme in biological samples
06/03/1997US5635345 Isolation of lymphocytes, incubation with labeled monoclonal antibody to a prosomal protein, measuring percentage of cells having this protein on cell surface, comparison with non-infected cells, human immunodeficiency virus, kits
06/03/1997US5635181 Pure immunogenic peptide encoded by dna sequence present in specified recombinant bacterial plasmid
06/03/1997US5635178 Inhibition of complement mediated inflammatory response using monoclonal antibodies specific for a component forming the C56-9 complex which inhibit the platelet or endothelial cell activating function of the C56-9 complex
06/03/1997US5635177 Useful in enabling role of tyrosine kinase receptor in cell growth and differentiation
05/1997
05/29/1997WO1997019177A1 SYNTHETIC MAMMALIAN α-N-ACETYLGLUCOSAMINIDASE AND GENETIC SEQUENCES ENCODING SAME
05/29/1997WO1997019171A1 Epithelial membrane protein-1
05/29/1997WO1997019170A1 Receptor and nucleic acid molecule encoding said receptor
05/29/1997WO1997019168A1 Sequestrin
05/29/1997WO1997019113A2 Monoclonal antiidiotypic antibodies (ab2) and uses thereof
05/29/1997WO1997019112A1 Inhibitory and non-inhibitory antigen binding polypeptides against human p450 enzymes
05/29/1997WO1997019111A2 Monoclonal antibodies anti-cd6 and their uses
05/29/1997WO1997019110A1 Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof
05/29/1997WO1997019101A1 Novel grb2 associating polypeptides and nucleic acids encoding therefor
05/29/1997WO1997019100A1 N-1-carboxyalkyl derivatives of lsd
05/29/1997WO1997018838A1 Therapeutic uses of humanized antibodies against alpha-4 integrin
05/29/1997WO1997018833A1 Methods of increasing lean tissue mass using ob protein compositions
05/29/1997WO1997018826A1 Fine tuned protegrins
05/29/1997WO1997018825A1 PROTEIN WHICH INTERACTS WITH THE HUNTINGTON'S DISEASE GENE PRODUCT, cDNA CODING THEREFOR, AND ANTIBODIES THERETO
05/29/1997WO1997018822A1 Vertebrate deltex proteins, nucleic acids, and antibodies, and related methods and compositions
05/29/1997WO1997018799A1 Use of a tnf alpha antagonist for treating neurogenic skin redness
05/29/1997WO1997009343A3 Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers
05/29/1997CA2629643A1 Inhibitory and non-inhibitory antigen binding polypeptides against human p450 enzymes
05/29/1997CA2358862A1 Methods of increasing lean tissue mass using ob protein compositions
05/29/1997CA2238610A1 Fine tuned protegrins
05/29/1997CA2238404A1 Vertebrate deltex proteins, nucleic acids, and antibodies, and related methods and compositions
05/29/1997CA2238075A1 Protein which interacts with the huntington's disease gene product, cdna coding therefor, and antibodies thereto
05/29/1997CA2238010A1 Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof
05/29/1997CA2237808A1 Therapeutic uses of humanized antibodies against alpha-4 integrin
05/29/1997CA2236163A1 Methods of increasing lean tissue mass using ob protein compositions
05/29/1997CA2236162A1 Epithelial membrane protein-1
05/29/1997CA2210705A1 Monoclonal antiidiotypic antibodies (ab2) and their uses
05/28/1997EP0775750A2 Preparation of proteins from pro-proteins by fusion proteins derived from furin or furinanalogs
05/28/1997EP0775747A2 Genes of the hop latent virus and methods for detecting the same
05/28/1997EP0775746A2 Coccidiosis poultry vaccine
05/28/1997EP0775742A2 Inhibiting transforming growth factor beta to prevent accumulation of axtracellular matrix
05/28/1997EP0775205A1 Novel cell surface receptor, antibody compositions, and methods of using same
05/28/1997EP0775202A1 Human interleukin variants generated by alternative splicing
05/28/1997EP0775199A1 Superoxide dismutase-4
05/28/1997EP0674734B1 Ski slope maintenance device
05/28/1997EP0670892A4 PURIFICATION, COMPOSITION AND SPECIFICITY OF HEPARINASE I, II, AND III FROM -i(FLAVOBACTERIUM HEPARINUM).
05/28/1997EP0653064A4 Clinical test for detection of alzheimer's disease.
05/28/1997EP0571420B1 Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis
05/28/1997EP0517918B1 Monoclonal antibody against cardiac glycoside and utilization thereof
05/28/1997EP0512112B1 Anti cd-4 antibodies blocking hiv-induced syncytia
05/28/1997EP0455705B1 Receptor membranes and ionophore gating
05/28/1997EP0403554B1 Placental isoferritins for the prognosis and diagnosis of immunosuppression
05/28/1997CN1150840A A method for detecting presence of mycobacterium species and kit and antibodies for use therein
05/28/1997CN1150805A Isolated peptides derived from MAGE tumor rejection antigen precursops which complex with HLA-A2 molecules
05/28/1997CN1150804A Fibroblast growth factor-10